The DOI matches its Crossref record; 178 of the 178 references it cites were found in a registry or an index.
Mechanisms of proteasome inhibitor action and resistance in cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Shi, Y., Yan, H., Frost, P., Gera, J., & Lichtenstein, A. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0068 · Cited by 368
RetractedAutophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., et al. (2006) · Nature · doi:10.1038/nature04724 · Cited by 3,882
BCL-2 family members and the mitochondria in apoptosis
Gross, A., McDonnell, J. M., & Korsmeyer, S. J. (1999) · Genes & Development · doi:10.1101/gad.13.15.1899 · Cited by 3,641
Loss of autophagy in the central nervous system causes neurodegeneration in mice
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J.-I., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., et al. (2006) · Nature · doi:10.1038/nature04723 · Cited by 3,500
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase
Harding, H. P., Zhang, Y., & Ron, D. (1999) · Nature · doi:10.1038/16729 · Cited by 3,310
Regulated Translation Initiation Controls Stress-Induced Gene Expression in Mammalian Cells
Harding, H. P., Novoa, I., Zhang, Y., Zeng, H., Wek, R., Schapira, M., & Ron, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00108-8 · Cited by 3,276
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,925
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
Richardson, P. G., Barlogie, B., Berenson, J., Singhal, S., Jagannath, S., Irwin, D., Rajkumar, S. V., Srkalovic, G., Alsina, M., Alexanian, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030288 · Cited by 2,632
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
Suppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma
Richardson, P. G., Sonneveld, P., Schuster, M. W., Irwin, D., Stadtmauer, E. A., Facon, T., Harousseau, J.-L., Ben-Yehuda, D., Lonial, S., Goldschmidt, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043445 · Cited by 2,491
Impairment of starvation-induced and constitutive autophagy in Atg7 -deficient mice
Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., Mizushima, N., Ohsumi, Y., Uchiyama, Y., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200412022 · Cited by 2,331
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
Aggresomes: A Cellular Response to Misfolded Proteins
Johnston, J. A., Ward, C. L., & Kopito, R. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.7.1883 · Cited by 2,148
Zinszner, H., Kuroda, M., Wang, X., Batchvarova, N., Lightfoot, R. T., Remotti, H., Stevens, J. L., & Ron, D. (1998) · Genes & Development · doi:10.1101/gad.12.7.982 · Cited by 2,014
Cantley, L. C., & Neel, B. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4240 · Cited by 2,006
Travers, K. J., Patil, C. K., Wodicka, L., Lockhart, D. J., Weissman, J. S., & Walter, P. (2000) · Cell · doi:10.1016/s0092-8674(00)80835-1 · Cited by 1,992
Aggresomes, inclusion bodies and protein aggregation
Kopito, R. R. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01852-3 · Cited by 1,921
McCullough, K. D., Martindale, J. L., Klotz, L.-O., Aw, T.-Y., & Holbrook, N. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1249-1259.2001 · Cited by 1,889
Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., & Huang, D. C. S. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.030 · Cited by 1,816
Letai, A., Bassik, M. C., Walensky, L. D., Sorcinelli, M. D., Weiler, S., & Korsmeyer, S. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00127-7 · Cited by 1,677
Autophagy in cell death: an innocent convict?
Levine, B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26390 · Cited by 1,676
Kawaguchi, Y., Kovacs, J. J., McLaurin, A., Vance, J. M., Ito, A., & Yao, T.-P. (2003) · Cell · doi:10.1016/s0092-8674(03)00939-5 · Cited by 1,524
Hideshima, T., Richardson, P. G. G., Chauhan, D., Palombella, V. J., Elliott, P. J., Adams, J., & Anderson, K. C. (2001) · PubMed · Cited by 1,508
Halliwell, B. (2001) · Drugs & Aging · doi:10.2165/00002512-200118090-00004 · Cited by 1,502
Proteasome inhibitors: a novel class of potent and effective antitumor agents.
Adams, J., Palombella, V. J., Sausville, E. A., Johnson, J. I., Destree, A. T., Lazarus, D. D., Maas, J., Pien, C. S., Prakash, S., & Elliott, P. J. (1999) · PubMed · Cited by 1,477
Shen, J., Chen, X., Hendershot, L., & Prywes, R. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00203-4 · Cited by 1,456
Translational Control Is Required for the Unfolded Protein Response and In Vivo Glucose Homeostasis
Scheuner, D., Song, B., McEwen, E., Liu, C., Laybutt, R., Gillespie, P., Saunders, T., Bonner-Weir, S., & Kaufman, R. J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00265-9 · Cited by 1,355
Plasma cell differentiation requires the transcription factor XBP-1
Reimold, A. M., Iwakoshi, N. N., Manis, J., Vallabhajosyula, P., Szomolanyi-Tsuda, E., Gravallese, E. M., Friend, D., Grusby, M. J., Alt, F., & Glimcher, L. H. (2001) · Nature · doi:10.1038/35085509 · Cited by 1,305
PI3K-Akt pathway: Its functions and alterations in human cancer
Osaki, M., Oshimura, M., & Ito, H. (2004) · Apoptosis · doi:10.1023/b:appt.0000045801.15585.dd · Cited by 1,264
HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS.
Pandey, U. B., Nie, Z., Batlevi, Y., McCray, B. A., Ritson, G. P., Nedelsky, N. B., Schwartz, S. L., DiProspero, N. A., Knight, M. A., Schuldiner, O., et al. (2007) · Nature · doi:10.1038/nature05853 · Cited by 1,234
Xiao, C., Srinivasan, L., Calado, D. P., Patterson, H. C., Zhang, B., Wang, J., Henderson, J. M., Kutok, J. L., & Rajewsky, K. (2008) · Nature Immunology · doi:10.1038/ni1575 · Cited by 1,228
IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis
Varfolomeev, E., Blankenship, J. W., Wayson, S. M., Fedorova, A. V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J. N., Elliott, L. O., Wallweber, H. J. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.030 · Cited by 1,218
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
Obeng, E. A., Carlson, L. M., Gutman, D. M., Harrington, W. J., Lee, K. P., & Boise, L. H. (2006) · Blood · doi:10.1182/blood-2005-08-3531 · Cited by 1,143
Feling, R. H., Buchanan, G. O., Mincer, T. J., Kauffman, C. A., Jensen, P. R., & Fenical, W. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200390115 · Cited by 1,057
Puthalakath, H., Huang, D. C. S., O’Reilly, L. A., King, S. M., & Strasser, A. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80456-6 · Cited by 1,054
Orchestrating the unfolded protein response in health and disease
Kaufman, R. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216886 · Cited by 1,015
Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
Keats, J. J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.-J., Van Wier, S., Tiedemann, R., Shi, C.-X., Sebag, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.003 · Cited by 983
S-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration
Uehara, T., Nakamura, T., Yao, D., Shi, Z.-Q., Gu, Z., Ma, Y., Masliah, E., Nomura, Y., & Lipton, S. A. (2006) · Nature · doi:10.1038/nature04782 · Cited by 906
NF-κB as a Therapeutic Target in Multiple Myeloma
Hideshima, T., Chauhan, D., Richardson, P., Mitsiades, C., Mitsiades, N., Hayashi, T., Munshi, N., Dang, L., Castro, A., Palombella, V., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200360200 · Cited by 893
Progression model for pancreatic cancer.
Hruban, R. H., Goggins, M., Parsons, J., & Kern, S. E. (2000) · PubMed · Cited by 879
Targeted disruption of the Chop gene delays endoplasmic reticulum stress–mediated diabetes
Oyadomari, S., Koizumi, A., Takeda, K., Gotoh, T., Akira, S., Araki, E., & Mori, M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14550 · Cited by 857
Protein Turnover Via Autophagy: Implications for Metabolism
Mizushima, N., & Klionsky, D. J. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093749 · Cited by 792
Shin, I., Yakes, F. M., Rojo, F., Shin, N.-Y., Bakin, A. V., Baselga, J., & Arteaga, C. L. (2002) · Nature Medicine · doi:10.1038/nm759 · Cited by 790
The development of proteasome inhibitors as anticancer drugs
Adams, J. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00120-5 · Cited by 781
Shi, Y., Vattem, K. M., Sood, R., An, J., Liang, J., Stramm, L., & Wek, R. C. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7499 · Cited by 774
Targeted disruption of the chop gene delays endoplasmic reticulum stress-mediated diabetes
Oyadomari, S., Koizumi, A., Takeda, K., Gotoh, T., Akira, S., Araki, E., & Mori, M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214550 · Cited by 752
Molecular sequelae of proteasome inhibition in human multiple myeloma cells
Mitsiades, N., Mitsiades, C. S., Poulaki, V., Chauhan, D., Fanourakis, G., Gu, X., Bailey, C., Joseph, M., Libermann, T. A., Treon, S. P., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202445099 · Cited by 741
Regulation of starvation- and virus-induced autophagy by the eIF2α kinase signaling pathway
Tallóczy, Z., Jiang, W., Virgin, H. W., Leib, D. A., Scheuner, D., Kaufman, R. J., Eskelinen, E.-L., & Levine, B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012485299 · Cited by 741
Translational control in the endoplasmic reticulum stress response
Ron, D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216784 · Cited by 726
Traenckner, E. B., Wilk, S., & Baeuerle, P. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06878.x · Cited by 710
Ding, W.-X., Ni, H.-M., Gao, W., Yoshimori, T., Stolz, D. B., Ron, D., & Yin, X.-M. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070188 · Cited by 708
Chauhan, D., Catley, L., Li, G., Podar, K., Hideshima, T., Velankar, M., Mitsiades, C., Mitsiades, N., Yasui, H., Letai, A., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.013 · Cited by 694
Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome
Demo, S. D., Kirk, C. J., Aujay, M. A., Buchholz, T. J., Dajee, M., Ho, M. N., Jiang, J., Laidig, G. J., Lewis, E. R., Parlati, F., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4086 · Cited by 678
Nguyen, M., Marcellus, R. C., Roulston, A., Watson, M., Serfass, L., Murthy Madiraju, S. R., Goulet, D., Viallet, J., Bélec, L., Billot, X., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709443104 · Cited by 659
Wang, W., Abbruzzese, J. L., Evans, D. B., Larry, L., Cleary, K. R., & Chiao, P. J. (1999) · PubMed · Cited by 651
Deng, J., Lu, P. D., Zhang, Y., Scheuner, D., Kaufman, R. J., Sonenberg, N., Harding, H. P., & Ron, D. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.23.10161-10168.2004 · Cited by 643
Zhang, P., McGrath, B., Li, S., Frank, A., Zambito, F., Reinert, J., Gannon, M., Ma, K., McNaughton, K., & Cavener, D. R. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3864-3874.2002 · Cited by 604
Proteasome inhibitors disrupt the unfolded protein response in myeloma cells
Lee, A.-H., Iwakoshi, N. N., Anderson, K. C., & Glimcher, L. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1334037100 · Cited by 601
Hideshima, T., Bradner, J. E., Wong, J., Chauhan, D., Richardson, P., Schreiber, S. L., & Anderson, K. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503221102 · Cited by 593
Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells.
Wu, M., Lee, H., Bellas, R. E., Schauer, S. L., Arsura, M., Katz, D., FitzGerald, M. J., Rothstein, T. L., Sherr, D. H., & Sonenshein, G. E. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00845.x · Cited by 587
Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341
Hideshima, T., Mitsiades, C., Akiyama, M., Hayashi, T., Chauhan, D., Richardson, P., Schlossman, R., Podar, K., Munshi, N. C., Mitsiades, N., et al. (2003) · Blood · doi:10.1182/blood-2002-08-2543 · Cited by 566
Houston, M. A., Abendroth, K., Baldwin, A. S., & Liu, R. (2001) · PubMed · doi:10.17615/k359-fr77 · Cited by 547
Requirement of NF-κB Activation to Suppress p53-Independent Apoptosis Induced by Oncogenic Ras
Mayo, M. W., Wang, C.-Y., Cogswell, P. C., Rogers-Graham, K. S., Lowe, S. W., Der, C. J., & Baldwin, A. S. (1997) · Science · doi:10.1126/science.278.5344.1812 · Cited by 533
WORKMAN, P., BURROWS, F., NECKERS, L., & ROSEN, N. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1391.012 · Cited by 521
An essential role in liver development for transcription factor XBP-1
Reimold, A. M., Etkin, A., Clauss, I., Perkins, A., Friend, D. S., Zhang, J., Horton, H. F., Scott, A., Orkin, S. H., Byrne, M. C., et al. (2000) · Genes & Development · doi:10.1101/gad.14.2.152 · Cited by 516
Bennett, E. J., Bence, N. F., Jayakumar, R., & Kopito, R. R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.021 · Cited by 509
Differential Effects of Endoplasmic Reticulum Stress-induced Autophagy on Cell Survival
Ding, W.-X., Ni, H.-M., Gao, W., Hou, Y.-F., Melan, M. A., Chen, X., Stolz, D. B., Shao, Z.-M., & Yin, X.-M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609267200 · Cited by 486
Activation of the cell death program by inhibition of proteasome function
Drexler, H. C. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.3.855 · Cited by 481
Ling, Y.-H., Liebes, L., Zou, Y., & Perez-Soler, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302559200 · Cited by 458
Oerlemans, R., Franke, N. E., Assaraf, Y. G., Cloos, J., van Zantwijk, I., Berkers, C. R., Scheffer, G. L., Debipersad, K., Vojtekova, K., Lemos, C., et al. (2008) · Blood · doi:10.1182/blood-2007-08-104950 · Cited by 454
XBP‐1 is required for biogenesis of cellular secretory machinery of exocrine glands
Lee, A., Chu, G. C., Iwakoshi, N. N., & Glimcher, L. H. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600903 · Cited by 452
PIK3CA as an oncogene in cervical cancer
Ma, Y.-Y., Wei, S.-J., Lin, Y.-C., Lung, J.-C., Chang, T.-C., Whang-Peng, J., Liu, J. M., Yang, D.-M., Yang, W. K., & Shen, C.-Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203597 · Cited by 434
Papandreou, C. N., Daliani, D. D., Nix, D., Yang, H., Madden, T., Wang, X., Pien, C. S., Millikan, R. E., Tu, S.-M., Pagliaro, L., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.106 · Cited by 434
Fribley, A., Zeng, Q., & Wang, C.-Y. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.22.9695-9704.2004 · Cited by 424
Liu, C. Y., Schröder, M., & Kaufman, R. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004454200 · Cited by 421
Extensive Immunoglobulin Production Sensitizes Myeloma Cells for Proteasome Inhibition
Meister, S., Schubert, U., Neubert, K., Herrmann, K., Burger, R., Gramatzki, M., Hahn, S., Schreiber, S., Wilhelm, S., Herrmann, M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2258 · Cited by 410
The proteasome as a target for cancer therapy.
Voorhees, P. M., Dees, E. C., O’Neil, B. H., & Orlowski, R. Z. (2003) · PubMed · Cited by 403
Proteasome and peptidase function in MHC-class-I-mediated antigen presentation
Kloetzel, P.-M., & Ossendorp, F. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.11.004 · Cited by 393
Ding, W.-X., & Yin, X.-M. (2008) · Autophagy · doi:10.4161/auto.5190 · Cited by 383
Genetic progression in the pancreatic ducts
Hruban, R. H., Wilentz, R. E., & Kern, S. E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65054-7 · Cited by 373
Development of the Proteasome Inhibitor PS-341
Adams, J. (2002) · The Oncologist · doi:10.1634/theoncologist.7-1-9 · Cited by 369
Functions of the proteasome: from protein degradation and immune surveillance to cancer therapy
Goldberg, A. L. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350012 · Cited by 367
Dejardin, E. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.007 · Cited by 344
Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma
Bross, P. F., Kane, R., Farrell, A. T., Abraham, S., Benson, K., Brower, M. E., Bradley, S., Gobburu, J. V., Goheer, A., Lee, S.-L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0781 · Cited by 343
Evan, G. I., Brown, L., Whyte, M., & Harrington, E. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80066-2 · Cited by 336
Proteasome Inhibitors Trigger NOXA-Mediated Apoptosis in Melanoma and Myeloma Cells
Qin, J.-Z., Ziffra, J., Stennett, L., Bodner, B., Bonish, B. K., Chaturvedi, V., Bennett, F., Pollock, P. M., Trent, J. M., Hendrix, M. J. C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0676 · Cited by 336
Nawrocki, S. T., Carew, J. S., Dunner, K., Boise, L. H., Chiao, P. J., Huang, P., Abbruzzese, J. L., & McConkey, D. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2394 · Cited by 324
Self-citationAntimyeloma activity of heat shock protein-90 inhibition
Mitsiades, C. S. (2005) · Blood · doi:10.1182/blood-2005-03-1158 · Cited by 319
Enhancement of radiosensitivity by proteasome inhibition: Implications for a role of NF-κB
Russo, S. M., Tepper, J. E., Baldwin, A. S., Liu, R., Adams, J., Elliott, P., & Cusack, J. C. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01446-8 · Cited by 318
Jiang, H.-Y., & Wek, R. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413660200 · Cited by 312
Bortezomib Sensitizes Pancreatic Cancer Cells to Endoplasmic Reticulum Stress-Mediated Apoptosis
Nawrocki, S. T., Carew, J. S., Pino, M. S., Highshaw, R. A., Dunner, K., Huang, P., Abbruzzese, J. L., & McConkey, D. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2370 · Cited by 309
Self-citationOxidative and Inflammatory Pathways in Parkinson’s Disease
Miller, R. L., James-Kracke, M., Sun, G. Y., & Sun, A. Y. (2009) · Neurochemical Research · doi:10.1007/s11064-008-9656-2 · Cited by 306
Proteasome Inhibition Measurements: Clinical Application
Lightcap, E. S., McCormack, T. A., Pien, C. S., Chau, V., Adams, J., & Elliott, P. J. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.5.673 · Cited by 301
Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy
Tan, T.-T., Degenhardt, K., Nelson, D. A., Beaudoin, B., Nieves-Neira, W., Bouillet, P., Villunger, A., Adams, J. M., & White, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.008 · Cited by 284
Urushitani, M., Kurisu, J., Tsukita, K., & Takahashi, R. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01211.x · Cited by 268
Yu, C., Rahmani, M., Conrad, D., Subler, M., Dent, P., & Grant, S. (2003) · Blood · doi:10.1182/blood-2003-03-0737 · Cited by 259
Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas
Mestre-Escorihuela, C., Rubio-Moscardo, F., Richter, J. A., Siebert, R., Climent, J., Fresquet, V., Beltran, E., Agirre, X., Marugan, I., Marín, M., et al. (2007) · Blood · doi:10.1182/blood-2006-06-026500 · Cited by 246
Guerrero, S., Casanova, I., Farré, L., Mazo, A., Capellá, G., & Mangues, R. (2000) · PubMed · Cited by 243
Nawrocki, S. T., Carew, J. S., Pino, M. S., Highshaw, R. A., Andtbacka, R. H. I., Dunner, K., Pal, A., Bornmann, W. G., Chiao, P. J., Huang, P., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2961 · Cited by 240
Self-citationDavenport, E. L., Moore, H. E., Dunlop, A. S., Sharp, S. Y., Workman, P., Morgan, G. J., & Davies, F. E. (2007) · Blood · doi:10.1182/blood-2006-11-053728 · Cited by 238
Aggresomes and Russell bodies: Symptoms of cellular indigestion?
Kopito, R. R., & Sitia, R. (2000) · EMBO reports · doi:10.1093/embo-reports/kvd052 · Cited by 230
Heat Shock Protein 70 Increases Tumorigenicity and Inhibits Apoptosis in Pancreatic Adenocarcinoma
Aghdassi, A., Phillips, P., Dudeja, V., Dhaulakhandi, D., Sharif, R., Dawra, R., Lerch, M. M., & Saluja, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1567 · Cited by 230
Blockade of Hsp27 overcomes Bortezomib/proteasome inhibitor PS-341 resistance in lymphoma cells.
Chauhan, D., Li, G., Shringarpure, R., Podar, K., Ohtake, Y., Hideshima, T., & Anderson, K. C. (2003) · PubMed · Cited by 229
A novel Bcl-2/Bcl-XL/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma
Chauhan, D., Velankar, M., Brahmandam, M., Hideshima, T., Podar, K., Richardson, P., Schlossman, R., Ghobrial, I., Raje, N., Munshi, N., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210028 · Cited by 229
Fernández, Y., Verhaegen, M., Miller, T. P., Rush, J. L., Steiner, P., Opipari, A. W., Lowe, S. W., & Soengas, M. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0686 · Cited by 222
Kabuta, T., Suzuki, Y., & Wada, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603337200 · Cited by 219
Proteasome Function Is Required for DNA Damage Response and Fanconi Anemia Pathway Activation
Jacquemont, C., & Taniguchi, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1015 · Cited by 212
Mimnaugh, E. G., Xu, W., Vos, M., Yuan, X., Isaacs, J. S., Bisht, K. S., Gius, D., & Neckers, L. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.551.3.5 · Cited by 210
Thompson, J. E., & Thompson, C. B. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.103 · Cited by 206
Miller, C. P., Ban, K., Dujka, M. E., McConkey, D. J., Munsell, M., Palladino, M., & Chandra, J. (2007) · Blood · doi:10.1182/blood-2006-03-013128 · Cited by 204
Self-citationYang, G., Ayala, G., Marzo, A. D., Tian, W., Frolov, A., Wheeler, T. M., Thompson, T. C., & Harper, J. W. (2002) · PubMed · Cited by 203
Chauhan, D., Singh, A., Brahmandam, M., Podar, K., Hideshima, T., Richardson, P., Munshi, N., Palladino, M. A., & Anderson, K. C. (2008) · Blood · doi:10.1182/blood-2007-08-105601 · Cited by 190
Flavonoids inhibit the expression of heat shock proteins.
Hosokawa, N., Hirayoshi, K., Nakai, A., Hosokawa, Y., Marui, N., Yoshida, M., Sakai, T., Nishino, H., Aoike, A., Kawai, K., et al. (1990) · Cell Structure and Function · doi:10.1247/csf.15.393 · Cited by 187
Nikrad, M., Johnson, T., Puthalalath, H., Coultas, L., Adams, J., & Kraft, A. S. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0260 · Cited by 180
Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition
Nikiforov, M. A., Riblett, M., Tang, W.-H., Gratchouck, V., Zhuang, D., Fernandez, Y., Verhaegen, M., Varambally, S., Chinnaiyan, A. M., Jakubowiak, A. J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708380104 · Cited by 173
Nawrocki, S. T., Bruns, C. J., Harbison, M. T., Bold, R. J., Sweeney‐Gotsch, B., Abbruzzese, J. L., Elliott, P. J., Adams, J., & McConkey, D. J. (2002) · PubMed · Cited by 170
Self-citationWilliams, S. A., Pettaway, C. A., Song, R., Papandreou, C. N., Logothetis, C. J., & McConkey, D. J. (2003) · PubMed · Cited by 164
Self-citationShin, D. H., Chun, Y.-S., Lee, D. S., Huang, L. E., & Park, J.-W. (2008) · Blood · doi:10.1182/blood-2007-11-120576 · Cited by 162
Nickeleit, I., Zender, S., Sasse, F., Geffers, R., Brandes, G., Sörensen, I., Steinmetz, H., Kubicka, S., Carlomagno, T., Menche, D., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.016 · Cited by 154
Effects of PS-341 on the activity and composition of proteasomes in multiple myeloma cells.
Altun, M., Galardy, P., Shringarpure, R., Hideshima, T., LeBlanc, R., Anderson, K., Ploegh, H., & Kessler, B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0506 · Cited by 149
The proteasome as a potential target for novel anticancer drugs and chemosensitizers
Landis‐Piwowar, K. R., Milacic, V., Chen, D., Yang, H., Zhao, Y., Chan, T. H., Yan, B., & Dou, Q. P. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.11.001 · Cited by 146
BH3 mimetics to improve cancer therapy; mechanisms and examples
Zhang, L., Ming, L., & Yu, J. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.08.002 · Cited by 144
A novel proteasome inhibitor NPI-0052 as an anticancer therapy
Chauhan, D., Hideshima, T., & Anderson, K. C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603406 · Cited by 141
Oxidative Stress-Associated Impairment of Proteasome Activity during Ischemia–Reperfusion Injury
Keller, J. N., Huang, F. F., Zhu, H., Yu, J., Ho, Y., & Kindy, M. S. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200010000-00008 · Cited by 140
CD28-mediated regulation of multiple myeloma cell proliferation and survival
Bahlis, N. J., King, A. M., Kolonias, D. S., Carlson, L. M., Liu, H. Y., Hussein, M. A., Terebelo, H. R., Byrne, G. E., Levine, B. L., Boise, L., et al. (2007) · Blood · doi:10.1182/blood-2006-03-012542 · Cited by 137
Bortezomib as a Potential Treatment for Prostate Cancer
Papandreou, C. N., & Logothetis, C. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2707 · Cited by 135
Nuclear factor-κB maintains TRAIL resistance in human pancreatic cancer cells
Khanbolooki, S., Nawrocki, S. T., Arumugam, T., Andtbacka, R. H. I., Pino, M. S., Kurzrock, R., Logsdon, C. D., Abbruzzese, J. L., & McConkey, D. J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0075 · Cited by 132
Self-citationNawrocki, S. T., Sweeney‐Gotsch, B., Takamori, R. K., & McConkey, D. J. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.59.3.1 · Cited by 131
Self-citationDai, Y., Rahmani, M., & Grant, S. (2003) · Oncogene · doi:10.1038/sj.onc.1206863 · Cited by 130
Liu, C. Y., Wong, H. N., Schauerte, J. A., & Kaufman, R. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112454200 · Cited by 130
p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells
Hideshima, T., Podar, K., Chauhan, D., Ishitsuka, K., Mitsiades, C. S., Tai, Y., Hamasaki, M., Raje, N. S., Hideshima, H., Schreiner, G. F., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208118 · Cited by 129
Zhu, H., Zhang, L., Dong, F., Guo, W., Wu, S., Teraishi, F., Davis, J. J., Chiao, P. J., & Fang, B. (2005) · Oncogene · doi:10.1038/sj.onc.1208683 · Cited by 128
A pivotal role for Mcl-1 in Bortezomib-induced apoptosis
Podar, K., Gouill, S. L., Zhang, J., Opferman, J. T., Zorn, E., Tai, Y., Hideshima, T., Amiot, M., Chauhan, D., Harousseau, J., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210679 · Cited by 125
Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy
Moretti, L., Yang, E. S.-H., Kim, K. W., & Lu, J. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.05.001 · Cited by 124
Nawrocki, S. T., Carew, J. S., Maclean, K. H., Courage, J. F., Huang, P., Houghton, J. A., Cleveland, J. L., Giles, F. J., & McConkey, D. J. (2008) · Blood · doi:10.1182/blood-2007-12-130823 · Cited by 122
Self-citationPaoluzzi, L., Gönen, M., Bhagat, G., Furman, R. R., Gardner, J. R., Scotto, L., Gueorguiev, V. D., Heaney, M. L., Manova, K., & O’Connor, O. A. (2008) · Blood · doi:10.1182/blood-2007-12-130781 · Cited by 121
(2004) · doi:10.1074/jbc.m312497200 · Cited by 119
Fratta, P., Engel, W. K., McFerrin, J., Davies, K. J. A., Lin, S. W., & Askanas, V. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62994-x · Cited by 111
Lü, S., Yang, J., Song, X., Gong, S., Zhou, H., Guo, L., Song, N., Bao, X., Chen, P., & Wang, J. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.138131 · Cited by 109
Kaluz, S., Kaluzová, M., & Stanbridge, E. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00552-06 · Cited by 108
Regulation of Bcl-2 Family Proteins by Posttranslational Modifications
Letai, A. G., & Kütük, Ö. (2008) · Current Molecular Medicine · doi:10.2174/156652408783769599 · Cited by 108
Ruiz, S., Krupnik, Y. V., Keating, M. J., Chandra, J., Palladino, M. A., & McConkey, D. J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0066 · Cited by 108
Self-citationBmi1 regulates memory CD4 T cell survival via repression of the Noxa gene
Yamashita, M., Kuwahara, M., Suzuki, A., Hirahara, K., Shinnaksu, R., Hosokawa, H., Hasegawa, A., Motohashi, S., Iwama, A., & Nakayama, T. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072000 · Cited by 107
Vitamin C Inactivates the Proteasome Inhibitor PS-341 in Human Cancer Cells
Zou, W., Yue, P., Lin, N., He, M., Zhou, Z., Lonial, S., Khuri, F. R., Wang, B., & Sun, S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0503 · Cited by 107
Oxidative stress in neurodegeneration and available means of protection
Fatokun, A. A., Stone, T. W., & Smith, R. A. (2008) · Frontiers in bioscience · doi:10.2741/2926 · Cited by 105
Enhanced Killing of Melanoma Cells by Simultaneously Targeting Mcl-1 and NOXA
Qin, J., Xin, H., Sitailo, L. A., Denning, M. F., & Nickoloff, B. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0747 · Cited by 100
Williams, S. A., & McConkey, D. J. (2003) · PubMed · Cited by 99
Self-citationGene expression analysis of B‐lymphoma cells resistant and sensitive to bortezomib*
Shringarpure, R., Catley, L. P., Bhole, D., Burger, R., Podar, K., Tai, Y., Kessler, B. M., Galardy, P. J., Ploegh, H. L., Tassone, P., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06132.x · Cited by 99
Moreau, A.-S., Jia, X., Ngo, H. T., Leleu, X. P., O’Sullivan, G., Alsayed, Y. M., Leontovich, A. A., Podar, K., Kutok, J. L., Daley, J. F., et al. (2007) · Blood · doi:10.1182/blood-2006-10-054577 · Cited by 98
Yu, C., Friday, B. B., Lai, J.-P., Yang, L., Sarkaria, J. N., Kay, N. E., Carter, C. A., Roberts, L. R., Kaufmann, S. H., & Adjei, A. A. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0235 · Cited by 98
Fuchs, D., Berges, C., Opelz, G., Daniel, V., & Naujokat, C. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21405 · Cited by 96
Shrader, M., Pino, M. S., Lashinger, L. M., Bar‐Eli, M., Adam, L., Dinney, C. P., & McConkey, D. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1224 · Cited by 85
Self-citationUntangling the unfolded protein response
Davenport, E. L., Morgan, G. J., & Davies, F. E. (2008) · Cell Cycle · doi:10.4161/cc.7.7.5615 · Cited by 84
Yerlikaya, A., Kimball, S. R., & Stanley, B. A. (2008) · Biochemical Journal · doi:10.1042/bj20080324 · Cited by 81
Redox homeostasis modulates the sensitivity of myeloma cells to bortezomib
Nerini‐Molteni, S., Ferrarini, M., Cozza, S., Caligaris‐Cappio, F., & Sitia, R. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07066.x · Cited by 72
Yu, J., & Tiwari, S. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.6.573 · Cited by 71
Shi, Y., Small, G. W., & Orlowski, R. Z. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9232-x · Cited by 67
Busse, A., Kraus, M., Na, I., Rietz, A., Scheibenbogen, C., Driessen, C., Blau, I. W., Thiel, E., & Keilholz, U. (2008) · Cancer · doi:10.1002/cncr.23224 · Cited by 64
Aberrant p27Kip1 promoter methylation in malignant melanoma
Worm, J., Bártková, J., Kirkin, A. F., Straten, P. T., Zeuthen, J., Bártek, J., & Guldberg, P. (2000) · Oncogene · doi:10.1038/sj.onc.1203891 · Cited by 62
Birle, D. C., & Hedley, D. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2722 · Cited by 58
Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells
Yang, W. P., Monroe, J. D., Zhang, Y., George, D. W., BREMER, E., & Li, H. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.11.033 · Cited by 55
Intracellular Protein Degradation and Its Therapeutic Implications
Hideshima, T., Bradner, J. E., Chauhan, D., & Anderson, K. C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2305 · Cited by 55
An, J., & Rettig, M. B. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0255 · Cited by 49
Wang, Z., Zhang, B., Yang, L., Ding, J., & Ding, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800806200 · Cited by 43
Magagnin, M. G., Koritzinsky, M., & Wouters, B. G. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.07.002 · Cited by 41
Cascone, T., Morelli, M. P., Morgillo, F., Kim, W., Rodolico, G., Pepe, S., Berrino, L., Lee, H., Heymach, J. V., & Ciardiello, F. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21444 · Cited by 41
Vaziri, S. A. J., Hill, J. E., Chikamori, K., Grabowski, D., Takigawa, N., Chawla‐Sarkar, M., Rybicki, L., Gudkov, A. V., Mekhail, T. M., Bukowski, R. M., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0222 · Cited by 33
Yang, H., Zhou, H., Li, B., Niu, G., & Chen, S. (2007) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9082-2 · Cited by 32
Ogino, S., Kawasaki, T., Ogawa, A., Kirkner, G. J., Loda, M. F., & Fuchs, C. S. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.09.014 · Cited by 25
Taking Garbage In, Tossing Cancer Out?
Garber, K. (2002) · Science · doi:10.1126/science.295.5555.612 · Cited by 23
Mutational analysis of Noxa gene in human cancers
Lee, S. H., Soung, Y. H., LEE, J. W., Kim, H. S., Lee, J., Kim, H. S., Lee, J., Park, J. Y., Cho, Y. G., Kim, C. J., et al. (2003) · Apmis · doi:10.1034/j.1600-0463.2003.1110602.x · Cited by 20
Assays for Proteasome Inhibition
Elliott, P. J., Soucy, T. A., Pien, C. S., Adams, J., & Lightcap, E. S. (2003) · Humana Press eBooks · doi:10.1385/1-59259-380-1:163 · Cited by 19
Velcade and Vitamin C: Too Much of a Good Thing?
Catley, L. P., & Anderson, K. C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2272 · Cited by 14
Cited by
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,165
The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation
Tornatore, L., Thotakura, A. K., Bennett, J., Moretti, M., & Franzoso, G. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.08.001 · Cited by 447
Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death
Vucic, D., Dixit, V. M., & Wertz, I. E. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3143 · Cited by 444
Zhu, K., Dunner, K., & McConkey, D. J. (2010) · Oncogene · doi:10.1038/onc.2009.343 · Cited by 338
Self-citationParlati, F., Lee, S. J., Aujay, M., Suzuki, E., Levitsky, K., Lorens, J. B., Micklem, D. R., Ruurs, P., Sylvain, C., Lu, Y., et al. (2009) · Blood · doi:10.1182/blood-2009-05-223677 · Cited by 324
Metadata
- Authors
- McConkey, D. J., & Zhu, K.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 11
- Issue
- 4-5
- Pages
- 164-179
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W2077247713
- Cited by
- 309
- References
- 178
- FWCI
- 11.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.